Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice

Pharmaceutical Research

Volumn 23, Issue 11, 2006, Pages 2621-2637

  Nair, Sujit ^a   Xu, Changjiang ^a   Shen, Guoxiang ^a   Hebbar, Vidya ^a   Gopalakrishnan, Avantika ^a   Hu, Rong ^a   Jain, Mohit Raja ^b   Lin, Wen ^a   Keum, Young Sam ^a   Liew, Celine ^c   Chan, Jefferson Y ^d   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Butylated hydroxyanisole; Chemoprevention; Global gene expression profiles; Microarray; Nuclear Factor E2 related factor 2

Indexed keywords

ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; NUCLEAR PROTEIN; PHENOL DERIVATIVE; PHOSPHATASE; PHOSPHOTRANSFERASE; REPRESSOR PROTEIN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; COMPUTER PROGRAM; CONTROLLED STUDY; DETOXIFICATION; DNA MICROARRAY; DOWN REGULATION; ELECTRON TRANSPORT; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; KNOCKOUT MOUSE; LIVER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMALL INTESTINE; UBIQUITINATION; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BONE MORPHOGENETIC PROTEINS; BUTYLATED HYDROXYANISOLE; FEMALE; GENE EXPRESSION PROFILING; INTESTINE, SMALL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 33750605111     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9099-x     Document Type: Article

References (41)

1. R. Yu, T. H. Tan, and A. N. T. Kong. Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J. Biol. Chem. 272:28962-28970 (1997).
2. M. Saito, H. Sakagami, and S. Fujisawa. Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). Anticancer Res. 23:4693-4701 (2003).
3. N. Festjens, M. Kalai, J. Smet, A. Meeus, R. Van Coster, X. Saelens, and P. Vandenabeele. Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death Differ. 13:166-169 (2006).
4. M. Kalai, G. Van Loo, T. Vanden Berghe, A. Meeus, W. Burm, X. Saelens, and P. Vandenabeele. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ. 9:981-984 (2002).
5. J. D. Hayes, D. J. Pulford, E. M. Ellis, R. McLeod, R. F. James, J. Seidegard, E. Mosialou, B. Jernstrom, and G. E. Neal. Regulation of rat glutathione S-transferase A5 by cancer chemopreventive agents: mechanisms of inducible resistance to aflatoxin B1. Chem. Biol. Interact. 111-112:51-67 (1998).
6. D. L. McCormick, N. Major, and R. C. Moon. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomitant or postcarcinogen antioxidant exposure. Cancer Res. 44:2858-2863 (1984).
7. F. E. Jones, R. A. Komorowski, and R. E. Condon. The effects of ascorbic acid and butylated hydroxyanisole in the chemoprevention of 1,2- dimethylhydrazine-induced large bowel neoplasms. J. Surg. Oncol. 25:54-60 (1984).
8. G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey. Anticarcinogenicity of monocyclic phenolic compounds. Eur. J. Cancer Prev. 11(Suppl 2):S101-S107 (2002).
9. R. Yu, S. Mandlekar, and A. N. T. Kong. Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c. Mol. Pharmacol. 58:431-437 (2000).
10. J. Alam, D. Stewart, C. Touchard, S. Boinapally, A. M. Choi, and J. L. Cook. Nrf2, a Cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274:26071-26078 (1999).
11. M. McMahon, K. Itoh, M. Yamamoto, A. Chanas, C. J. Henderson, L. I. McLellan, C. R. Wolf, C. Cavin, and J. D. Hayes. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61:3299-3307 (2001).
12. R. K. Thimmulappa, K. H. Mai, S. Srisuma, T. W. Kensler, M. Yamamoto, and S. Biswal. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196-5203 (2002).
13. H. J. Prochaska, M. J. De Long, and P. Talalay. On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Proc. Natl. Acad. Sci. USA 82:8232-8236 (1985).
14. W. Li, M. R. Jain, C. Chen, X. Yue, V. Hebbar, R. Zhou, and A. N. Kong. Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J. Biol. Chem. 280:28430-28438 (2005).
15. G. Shen, V. Hebbar, S. Nair, C. Xu, W. Li, W. Lin, Y. S. Keum, J. Han, M. A. Gallo, and A. N. Kong. Regulation of Nrf2 transactivation domain activity. The differential effects of mitogenactivated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J. Biol. Chem. 279:23052-23060 (2004).
16. Y. S. Keum, E. D. Owuor, B. R. Kim, R. Hu, and A. N. Kong. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm. Res. 20:1351-1356 (2003).
17. C. Chenand and A. N. Kong. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic. Biol. Med. 36:1505-1516 (2004).
18. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J. D. Engel, and M. Yamamoto. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76-86 (1999).
19. S. Dhakshinamoorthy and A. K. Jaiswal. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductase1 gene. Oncogene 20:3906-3917 (2001).
20. N. Wakabayashi, A. T. Dinkova-Kostova, W. D. Holtzclaw, M. I. Kang, A. Kobayashi, M. Yamamoto, T. W. Kensler, and P. Talalay. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. USA 101:2040-2045 (2004).
21. X. Yu and T. Kensler. Nrf2 as a target for cancer chemoprevention. Mutat. Res. 591:93-102 (2005).
22. S. Dhakshinamoorthy and A. K. Jaiswal. Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:Quinone oxidoreductase1 gene. J. Biol. Chem. 275:40134-40141 (2000).
23. A. N. Kong, R. Yu, W. Lei, S. Mandlekar, T. H. Tan, and D. S. Ucker. Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis. The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis. Restor. Neurol. Neurosci. 12:63-70 (1998).
24. K. Chan, R. Lu, J. C. Chang, and Y. W. Kan. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. USA 93:13943-13948 (1996).
25. G. Shen, C. Xu, R. Hu, M. R. Jain, S. Nair, W. Lin, C. S. Yang, J. Y. Chan, and A. N. Kong. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm. Res. 22:1805-1820 (2005).
26. G. Shen, C. Xu, R. Hu, M. R. Jain, A. Gopalkrishnan, S. Nair, M. T. Huang, J. Y. Chan, and A. N. Kong. Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol. Cancer Ther. 5:39-51 (2006).
27. W. Lin, G. Shen, X. Yuan, M. R. Jain, S. Yu, A. Zhang, J. D. Chen, and A. N. Kong. Regulation of Nrf2 Transactivation Domain Activity by p160 RAC3/SRC3 and Other Nuclear Co-Regulators. J. Biochem. Mol. Biol. 39(3):304-310.
28. K. I. Borroz, T. M. Buetler, and D. L. Eaton. Modulation of gamma-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole. Toxicol. Appl. Pharmacol. 126:150-155 (1994).
29. T. M. Buetler, E. P. Gallagher, C. Wang, D. L. Stahl, J. D. Hayes, and D. L. Eaton. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol 135:45-57 (1995).
30. L. I. McLellan, D. J. Harrison, and J. D. Hayes. Modulation of glutathione S-transferases and glutathione peroxidase by the anticarcinogen butylated hydroxyanisole in murine extrahepatic organs. Carcinogenesis 13:2255-2261 (1992).
31. S. A. Chanas, Q. Jiang, M. McMahon, G. K. McWalter, L. I. McLellan, C. R. Elcombe, C. J. Henderson, C. R. Wolf, G. J. Moffat, K. Itoh, M. Yamamoto, and J. D. Hayes. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 365:405-416 (2002).
32. A. R. Tanaka, K. Tanabe, M. Morita, M. Kurisu, Y. Kasiwayama, M. Matsuo, N. Kioka, T. Amachi, T. Imanaka, and K. Ueda. ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1). J. Biol. Chem. 277:40142-40147 (2002).
33. A. S. Verkman. More than just water channels: unexpected cellular roles of aquaporins. J. Cell Sci. 118:3225-3232 (2005).
34. Y. Shi and J. Massague. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700 (2003).
35. R. Vittal, Z. E. Selvanayagam, Y. Sun, J. Hong, F. Liu, K. V. Chin, and C. S. Yang. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol. Cancer Ther. 3:1091-1099 (2004).
36. G. R. Beck Jr., B. Zerler, and E. Moran. Gene array analysis of osteoblast differentiation. Cell Growth Differ. 12:61-83 (2001).
37. L. Yang, K. Yamasaki, Y. Shirakata, X. Dai, S. Tokumaru, Y. Yahata, M. Tohyama, Y. Hanakawa, K. Sayama, and K. Hashimoto. Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the canonical pathway of Wnt signaling in normal keratinocytes. J. Dermatol. Sci. (2006).
38. H. Motohashi, F. Katsuoka, J. D. Engel, and M. Yamamoto. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. USA 101:6379-6384 (2004).
39. J. M. Lizcano, S. Alrubaie, A. Kieloch, M. Deak, S. J. Leevers, and D. R. Alessi. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. Biochem. J. 374:297-306 (2003).
40. J. Dornand, C. Sekkat, J. C. Mani, and M. Gerber. Lipoxygenase inhibitors suppress IL-2 synthesis: relationship with rise of [Ca++]i and the events dependent on protein kinase C activation. Immunol. Lett. 16:101-106 (1987).
41. M. Ruzzene, A. Donella-Deana, A. Alexandre, M. A. Francesconi, and R. Deana. The antioxidant butylated hydroxytoluene stimulates platelet protein kinase C and inhibits subsequent protein phosphorylation induced by thrombin. Biochim. Biophys. Acta 1094:121-129 (1991).